Emerging Applications: Kidney & Liver

GLP-1 RAs have demonstrated renoprotective actions, slowing chronic kidney disease progression, and positively impact liver health by improving steatosis and liver inflammation in non-alcoholic fatty liver disease (NAFLD).

Sources

• GLP-1 receptor agonists and SGLT2 inhibitors: new anti-aging tools? - PMC
• GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives - PMC
• Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty liver disease?
• New GLP-1 Heart & Kidney Benefits: Why Doctors Prescribe Now - Ubie
• GLP-1 Receptor Agonists (GLP-1 RAs) | National Kidney Foundation

Open the full topic